Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$135.66 - $197.02 $949 - $1,379
7 Added 63.64%
18 $2,000
Q4 2022

Feb 08, 2023

BUY
$118.38 - $210.04 $1,302 - $2,310
11 New
11 $1,000
Q4 2021

Feb 11, 2022

SELL
$225.82 - $368.51 $575,841 - $939,700
-2,550 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$221.9 - $484.47 $565,845 - $1.24 Million
2,550 New
2,550 $981,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Okabena Investment Services Inc Portfolio

Follow Okabena Investment Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Okabena Investment Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Okabena Investment Services Inc with notifications on news.